SUBIA (SUBIA Sino-US Biomedical Investment Association) and SUBIA Forum is a biomedical professional organization established between China and the United States. It’s founded in 2014 and main offices are located in New York and Shanghai. SUBIA has over 3000 members over the world. Its members are mainly composed of research scientists, entrepreneurs, doctors, scholars, IP lawyers, medical policy maker, business and academic leaders, as well as over 600 members of angel and VC/PE investment capitalists in the field of healthcare. Its Management Committee is composed of 13 professional representatives in US and China.
SUBIA has been playing active role in linking the Chinese and US biopharmaceutical industries for promoting drug innovation and cross border investment. During the past two years. SUBIA has held seminars and forums covering advanced technologies and drug discovery platforms of target drugs, immunology, gene therapy, genetic testing, CRO Service, IVD, in vitro diagnostic, medicine device and molecular diagnosis etc. Since its inception, SUBIA has helped investor to reach the potential projects for investment and assisted academic and industrial professionals in forming startup companies and technical transfer in US and China as well as rest of the world.